Skip to main content

Advertisement

Log in

Pharmacogenomics

  • Technologies
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Abstract

Information on human genetic variance is only just beginning to be used in drug development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Putney, S.D. et al. Nature 302, 718–721 (1983).

    Article  CAS  Google Scholar 

  2. Cooper, T.A. et al. Science 226, 979–982 (1984).

    Article  CAS  Google Scholar 

  3. Zipkin, I. et al. BioCentury Oct. 20, A5 (1997).

    Google Scholar 

  4. Reddy D.S. et al. Methods Find. Exp. Clin. Pharmacol. 18, 261– 271 (1996).

    CAS  PubMed  Google Scholar 

  5. Jerkovic, R. et al. Cell Struct. Funct. 22, 147– 153 (1997).

    Article  CAS  Google Scholar 

  6. Olschwang, S. et al. Proc. Natl. Acad. Sci. USA 94, 12122– 12127(1997).

    Article  CAS  Google Scholar 

  7. Persidis, A. Nat. Biotechnol. 15, 1409–1411 (1997).

    Article  CAS  Google Scholar 

  8. Rioux, P.P. Am. J. Health Syst. Pharm. 57, 887– 898 (2000).

    Article  CAS  Google Scholar 

  9. McCarthy, J.J. & Hilfiker, R. Nat. Biotechnol. 18 , 505–508 (2000).

    Article  CAS  Google Scholar 

  10. Issa, A.M. Trends Pharmacol. Sci. 21, 247–249 (2000).

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pharmacogenomics. Nat Biotechnol 18 (Suppl 10), IT40–IT42 (2000). https://doi.org/10.1038/80079

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/80079

  • Springer Nature America, Inc.

This article is cited by

Navigation